Trial intelligence / Profile preview

Sertraline vs Nortriptyline for Late-Life Depression

NCT00000378Phase 4Completed

Sponsor
New York State Psychiatric Institute
Start
Jul 1997
Primary completion
Jun 2002
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of sertraline in major depressive disorder (MDD) (2 arms), sponsored by New York State Psychiatric Institute. Primary endpoint: Hamilton Rating Scale for Depression at 12 weeks. Started Jul 1997; status: completed.

02

Drugs

sertraline
03

Conditions

major depressive disorder (MDD)

Beyond the preview

Go deeper on NCT00000378.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00000378.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call